Protocol Development and Quality Improvement
Provide data for QA or research initiatives.
Accreditation purposes
Promotional reasons
Financial impact can be analyzed and used to justify time spent in that area.
Reports
Statistical interpretations of services
Satisfaction surveys of their services
Risk reduction
| d. | Peer review |
|---|
Publication
Return on investment data
Future initiatives
opportunities as possible β this increases the visibility and corroborates the importance of the pharmacy
department and the critical care pharmacy services. Box 2 lists examples of pharmacotherapeutic
following:
ICU committee
Subcommittees of P&T including ICU, neurology, pediatrics, anticoagulation, or other
subspecialty committees.
P&T committee
QA committee
| d. | Medication use review committee |
|---|
Formulary committee
Medication safety committee
Antimicrobial stewardship committee
Medical executive committee β Engages with potential expansion of pharmacy services or cost
avoidance
monthly or quarterly (Figure 2). These data should include the type of intervention (Figure 3) and both
the raw drug cost savings derived from changing to less expensive drugs and the outcome cost savings
such as preventing an adverse event and decreasing the LOS (Figure 4).